Jatenzo - An Oral Testosterone for Hypogonadism
Date: June 28, 2021
Issue #:
1627Summary:
An oral formulation of testosterone undecanoate
(Jatenzo– Clarus) has been approved by the FDA for
treatment of adult men with conditions associated
with a deficiency of endogenous testosterone, such as
Klinefelter syndrome, orchiectomy, toxic damage from
chemotherapy or alcohol, or pituitary-hypothalamic
injury from tumors, trauma, or radiation.Jatenzo is
not approved for treatment of low testosterone levels
solely due to aging. It is the first oral testosterone
formulation to be approved in the US.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: admin Tags: Androderm AndroGel Aveed Delatestryl Depo-Testosterone Fortesta Hypogonadism Jatenzo Natesto Testim Testopel Xyosted Source Type: research
More News: Alcoholism | AndroGel | Chemotherapy | Drugs & Pharmacology | Klinefelter's Syndrome | Low Testosterone | Testosterone Injection | Toxicology